Anavex Life Sciences Names AMEOS CEO Running 85 Hospitals, 23 Care Facilities to Board
Anavex Life Sciences appointed Dr. Axel Paeger, MD, MBA, MBI, to its board to leverage his 30 years of leadership as CEO of AMEOS Group, which operates 85 hospitals and 23 long-term care facilities serving 500,000 patients. His psychiatric and neurological expertise will guide advancement of late-stage CNS drug candidates.
1. Board Appointment
Anavex Life Sciences has appointed Dr. Axel Paeger, MD, MBA, MBI, to its board of directors, effective February 23, 2026. The company aims to leverage his extensive leadership in healthcare to advance its clinical-stage pipeline targeting CNS disorders.
2. Dr. Paeger’s Experience and Impact
Dr. Paeger brings over 30 years of experience as Chief Executive Officer of the AMEOS Group, which operates 85 hospitals and 23 long-term care facilities serving approximately 500,000 patients annually in the DACH region. His expertise in psychiatric and neurological inpatient care is expected to support progression of Anavex's late-stage drug candidates for Alzheimer’s, Parkinson’s and related neurological disorders.